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The genus Cyprinivirus consists of a growing list of phylogenetically related viruses, some of which cause
severe economic losses to the aquaculture industry. The archetypal member, cyprinid herpesvirus 3
(CyHV-3) causes mass mortalities worldwide in koi and common carp. A CyHV-3 mutant was described
previously that is attenuated in vivo by a deletion affecting two genes (ORF56 and ORF57). The relative
contributions of ORF56 and ORF57 to the safety and efficacy profile of this vaccine candidate have now
been assessed by analysing viruses individually deleted for ORF56 or ORF57. Inoculation of these viruses
into carp demonstrated that the absence of ORF56 did not affect virulence, whereas the absence of ORF57
led to an attenuation comparable to, though slightly less than, that of the doubly deleted virus. To
demonstrate further the role of ORF57 as a key virulence factor, a mutant retaining the ORF57 region but
unable to express the ORF57 protein was produced by inserting multiple in-frame stop codons into the
coding region. Analysis of this virus in vivo revealed a safety and efficacy profile comparable to that of the
doubly deleted virus. These findings show that ORF57 encodes an essential CyHV-3 virulence factor. They
also indicate that ORF57 orthologues in other cypriniviruses may offer promising targets for the rational
design of attenuated recombinant vaccines.
© 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
The Alloherpesviridae is one of three families in the order Her-
pesvirales, and consists of herpesviruses that infect fish or am-
phibians (Boutier et al., 2015a). It currently contains 12 species
distributed into four genera. One of these genera, Cyprinivirus,
comprises a growing list (Doszpoly et al., 2015) of phylogenetically
related viruses, some of which cause severe economic losses to the
aquaculture industry. These include cyprinid herpesvirus 2
(CyHV-2; also known as goldfish hematopoietic necrosis virus),
which causes a lethal disease in goldfish (Carassius auratus) and
gibel carp (C. gibelio) (Xu et al., 2013, 2014; Ito and Maeno, 2014),
anguillid herpesvirus 1 (AngHV-1), which is responsible for mor-
talities of up to 30% in cultured and wild European and Japanese eel
populations (Anguilla anguilla and A. japonica) (van Beurden et al.,
2012), and cyprinid herpesvirus 3 (CyHV-3; also known as koi(B43b), Faculty of Veterinary
, University of Liege, B-4000,
erplasschen).
r B.V. This is an open access articleherpesvirus), which is the etiological agent of a lethal disease in
common carp (Cyprinus carpio) and koi carp (Adamek et al., 2014;
Rakus et al., 2013).
CyHV-3 is considered to be the archetypal fish alloherpesvirus
(Boutier et al., 2015a). Since its emergence in the 1990s, this virus
has caused severe economic losses to the carp culture industry
worldwide (Adamek et al., 2014; Rakus et al., 2013). For example,
outbreaks of CyHV-3 that occurred in Indonesia in 2002 and 2003
were estimated to have resulted in economic losses amounting to
US$15 million (Bondad-Reantaso et al., 2005; Sunarto et al., 2005).
CyHV-3 is also provoking a societal impact in developing countries
by affecting familial aquaculture and thereby limiting access to one
of the cheapest sources of animal protein (Boutier et al., 2015a). In
addition, it is having an ecological impact by inducing carp mor-
talities in natural habitats (Ito et al., 2014; Uchii et al., 2013).
Various types of vaccine candidate against CyHV-3 have been
developed (Boutier et al., 2015b; O'Connor et al., 2014; Perelberg
et al., 2008). Among these, attenuated vaccines seem the most
promising because they are more likely to suit practical field con-
straints, such as the need for mass vaccination of fish weighing only
a few grams each. Also, scientific advances are increasinglyunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Guzman, 2012), including deleting genes from a viral genome in a
precise way that precludes reversion to virulence (Meeusen et al.,
2007). This approach has been taken for CyHV-3 by targeting
various open reading frame (ORFs), including ORF16, ORF55,
ORF123 and ORF134, which encode a G protein-coupled receptor
(GPCR), thymidine kinase (TK), deoxyuridine triphosphatase
(dUTPase) and interleukin-10, respectively. However, none of the
recombinants lacking these genes has been shown to have a safety
and efficacy profile compatible with their use as attenuated vac-
cines (Costes et al., 2008; Fuchs et al., 2011; Ouyang et al., 2013).
This list of failures illustrates the difficulties of predicting the
impact of gene deletions in alloherpesviruses, particularly as there
is little genetic similarity between these viruses and themuchmore
extensively studied members of the family Herpesviridae (Boutier
et al., 2015a).
Recently, we reported the development of an attenuated CyHV-3
vaccine candidate compatible with mass vaccination of carp
(Boutier et al., 2015b). The attenuation depends on an accidentally
generated deletion affecting two divergently transcribed genes
(ORF56 and ORF57), removing most of ORF56 (leaving less than 10%
at the 30 end) and part of ORF57 (leaving about 75% at the 30 end).
Using in vivo imaging system and quantitative PCR, we demon-
strated that this doubly deleted virus and the wild-type parental
virus have similar tropisms. However, compared to the parental
wild-type virus, the spread of the deleted virus to the other organs
was much slower, and its replication was reduced in intensity and
duration (Boutier et al., 2015b). The relative contributions of ORF56
and ORF57 to the safety and efficacy profile of the doubly deleted
virus are not known. The functions of these ORFs are similarly not
known, although ORF57 is conserved in all cypriniviruses and
ORF56 is conserved only among cypriniviruses infecting cyprinid
fish (Davison et al., 2013; van Beurden et al., 2010). In the present
study, we investigated the relative contributions of ORF56 and
ORF57 to the safety and efficacy profile of the doubly deleted virus.
The results demonstrated that ORF57 encodes an essential CyHV-3
virulence factor, and raised the possibility that ORF57 orthologues
in other cypriniviruses may present promising targets for rational
design of attenuated vaccines.2. Materials and methods
2.1. Cells and viruses
CCB cells (Neukirch et al., 1999) were cultured as described
previously (Boutier et al., 2015b). The CyHV-3 FL and M3 strains
were isolated from the kidney tissue of koi carp that died during
independent CyHV-3 outbreaks in Belgium. The FL bacterial artifi-
cial chromosome plasmid (BAC) was generated from the FL strain
(Costes et al., 2008). The mutant deleted for ORF56 and ORF57
(D56-57) was produced from this BAC (Boutier et al., 2015b).2.2. Production of recombinant viruses
2.2.1. Generation of recombinant BACs
Figs. 1 and 4 outline the strategies used to generate various re-
combinant viruses from the FL BAC (Costes et al., 2008) on the basis
of galK positive/negative selection in bacteria (Costes et al., 2008;
Warming et al., 2005). Recombination cassettes encoding galK
were produced by PCR, using the primers listed in Table S1 and the
pgalK vector as template. The ORF57 Rev and ORF57 NS cassettes
were amplified from plasmids encoding a wild-type (57Rev) and
mutated (57NS) ORF57, respectively, by using the primers listed in
Table S1. Details of the ORF57 NS cassette encoding in-frame stopcodons in ORF57 are given in Fig. 4A.
2.2.2. Generation of recombinant viruses from BACs
Recombinant BACs were co-transfected into CCB cells with the
pGEMT-TK plasmid or the pEFIN3 NLS Cre plasmid (both at a mo-
lecular ratio of 1:75) by using polyethylenimine (3 mg per 1 mg DNA)
(Costes et al., 2008). Transfection with the pGEMT-TK plasmid
induced recombination upstream and downstream of the BAC
cassette, leading to reversion to a wild-type TK (ORF55) locus (FL
BAC revertant viruses). Transfection with the pEFIN3 NLS Cre
plasmid induced expression of a nuclear Cre recombinase and
caused cre-loxP-mediated excision of the BAC cassette, leading to
viruses expressing a truncated form of TK due to the retention of a
172 bp sequence from the BAC cassette in the TK locus (FL BAC
excised viruses). Since the BAC cassette encodes the enhanced
green fluorescent protein (EGFP), EGFP-negative plaques were
picked and amplified in both cases. The strategies are shown in
Figs. 1 and 4, which also specify in bold font the short names for the
recombinant viruses that are used below.
2.2.3. Genetic characterization of recombinant viruses
CyHV-3 recombinants were characterized by restriction frag-
ment length polymorphism (RFLP) analysis using SacI digestion,
Southern blot analysis, sequencing of manipulated regions, and
full-length genome sequencing as described previously (Boutier
et al., 2015b; Costes et al., 2009; Ouyang et al., 2013; Rakus et al.,
2017).
2.3. In vitro experiments
2.3.1. Antibodies against the ORF56 and ORF57 proteins
Mouse polyclonal antibodies (pAbs) directed against the pre-
dicted unstructured domain (analysed by using IUPred, http://iupre
d.enzim.hu) of the ORF56 protein (pORF56) (specified by co-
ordinates 98049-99398, NC_009127.1) or against the full-length
ORF57 protein (pORF57) (specified by coordinates 99382-100803,
NC_009127.1) were produced by DNA immunization using a com-
mercial service (DelphiGenetics). Mouse monoclonal antibody
(mAb) 6B2 was selected from a bank of mouse mAbs raised against
CyHV-3 structural proteins, and recognizes an epitope in the last
165 amino acid residues of pORF57 (specified by coordinates
100309-100803, NC_009127.1).
2.3.2. Indirect immunofluorescent staining
Cells were fixed in phosphate-buffered saline (PBS) containing
4% (w/v) paraformaldehyde, and permeabilized in PBS containing
0.1% (v/v) NP-40. Incubation of antibodies and washes were per-
formed in PBS containing 10% (v/v) foetal calf serum (FCS). Mouse
pAbs raised against pORF56 (diluted 1:500), mouse mAb 6B2 raised
against pORF57 (diluted 1:2500), mouse pAbs raised against
pORF57 (diluted 1:500), and rabbit pAbs raised against CyHV-3
structural proteins (diluted 1:1500) were used as primary anti-
bodies (37 C for 1 h). Alexa Fluor 488 GAM IgG(H þ L) and Alexa
Fluor 568 GARb IgG(H þ L) (Invitrogen) were used as secondary
antibodies (37 C for 30 min). Cell nuclei were stained by using TO-
PRO-3 iodide (Invitrogen, 1:1000 at room temperature for 15 min)
or DAPI dilactate (Invitrogen, 1:30,000 in PBS at room temperature
for 5 min). After washing, cells were mounted by using Prolong
Gold antifade reagent (Invitrogen). Confocal analyses were per-
formed by using Leica SP2 and SP5 instruments.
2.3.3. Plaque size assay
Cultures of CCB cells in six-well plates were inoculated with
100e200 plaque-forming units (PFU)/well of virus for 2 h and
overlaid with Dulbecco's modified essential medium (DMEM,
Fig. 1. Production of ORF56 and ORF57 galK singly deleted recombinants. (A) Schematic representation of the structure of the ORF56-57 region. CyHV-3 ORFs are represented by
arrows, and predicted promoters are represented by angular black arrows. In-frame ATG codons in ORF57 are indicated by dark grey vertical lines. Regions of ORF56 or ORF57 were
replaced by a galK cassette (black rectangle) in order to preserve the predicted promoters of the non-deleted ORF. All coordinates correspond to the reference CyHV-3 sequence
available in GenBank (NC_009127.1). (B) Flow chart of the production of the ORF56 and ORF57 galK singly deleted recombinants. Short names for the recombinants used in the text
are shown in bold font. Genotypes for ORF55 (TK), ORF56 and ORF57 are shown to the right. WT, wild-type; Del, deleted; trunc, truncated.
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carboxymethylcellulose (medium viscosity, Sigma). Viral plaques
were treated for indirect immunofluorescent staining by usingmAb
2F12, which recognizes an unknown CyHV-3 epitope. Viral plaques
were imaged by using a Nikon A1R confocal microscope, and pla-
que size was measured by using the ImageJ software.
2.3.4. Growth curve assays
Triplicate cultures of CCB cells were infected with virus at 0.05or 1 PFU/cell. After an incubation period of 2 h, the cells were
washed with PBS and overlaid with DMEM containing 4.5 g/L
glucose and 10% (v/v) FCS. The supernatant was removed from
infected cultures at successive intervals (0, 2, 4 and 6 days post-
infection (dpi)) and stored at 80 C. Viral titration was carried
out by duplicate plaque assays in CCB cells as described previously
(Costes et al., 2009).
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2.4.1. Fish
Common carpwere kept in 60 L tanks at 24 C.Water parameters
were checked twice perweek.Microbiological, parasitic and clinical
examinations carried out immediately prior to the experiments
demonstrated that the fish were healthy. All experiments were
preceded by an acclimation period of at least 2 weeks.
2.4.2. Inoculation of fish
Two modes of inoculation were used: immersion in infectious
water, and cohabitationwith newly infected fish. For inoculation by
immersion, fish were kept in water containing virus for 2 h under
constant aeration, having adapted the volume according to fish size
and fish number to utilise a biomass of approximately 10%. At the
end of the incubation period, the fish were returned to their initial
tank. For inoculation by cohabitation, newly infected fish were
produced by immersion of naïve fish for 2 h in water containing
400 PFU/ml of the virus. At the end of the incubation period, the
newly infected fish were released into the tank of fish to be infected
at a ratio of 2:20.
2.4.3. Ethics statement
The experiments, maintenance and care of fish complied with
the guidelines of the European Convention for the Protection of
Vertebrate Animals used for Experimental and other Scientific
Purposes (CETS n 123). The animal studies were approved by the
local ethics committee of the University of Liege, BelgiumFig. 2. Expression of pORF56 and pORF57 by singly deleted recombinants. CCB cells were
dpi to indirect immunofluorescent staining as indicated at the top, detecting pORF56 (green)
Scale bars ¼ 20 mm.(laboratory accreditation No.1610008, protocol no.1059). All efforts
were made to minimize suffering.
2.5. Statistical analysis
Viral plaques sizes and viral growth curves were compared by
two-way ANOVAwith interactions followed by Bonferroni post-hoc
test. Survival curves were compared by using Logrank tests. Sta-
tistical significance was represented as follows: ns, not significant;
*, p < 0.05; **, p < 0.01; and ***, p < 0.001.
3. Results
3.1. Production of ORF56 and ORF57 singly deleted recombinants
To investigate the relative contributions of ORF56 and ORF57 to
the attenuation reported for D56-57 (Boutier et al., 2015b), ORF56
and ORF57 galK singly deleted recombinants were produced
(Fig. 1). The deletions were informed by predictions of promoter
locations (made using http://fruitfly.org/seq_tools/promoter.html),
in order to minimize the risk of a deletion in one gene having a
polar effect on expression of the other. The strategy relied on
inducing a specific deletion within the target ORF and simulta-
neously inserting a galK cassette, thereby theoretically disrupting
expression of the remaining downstream sequence. The BAC
cassette was removed by Cre-recombinase-mediated excision,
leading to truncation of TK. As shown in Fig. 1, two independent
recombinants were produced for each ORF (TKtrunc D56-1galk andinfected with the viruses indicated on the left at 0.05 PFU/cell. Cells were subjected at 1
, pORF57 (green, using mAb 6B2), CyHV-3 structural proteins (red) and DNA (TO-PRO 3).
Fig. 3. Effect of ORF56 and ORF57 deletion on CyHV-3 virulence. The virulence of the indicated recombinants was tested in carp (n ¼ 30, average weight 3.77 g ± 1.95 g, 7 months
old). Fish were infected with the indicated viruses by immersion for 2 h in water containing 4 (,), 40 (B), or 400 (x) PFU/ml, or mock infected (◊). Data are presented as survival
rates expressed in relation to the number of fish at time of inoculation.
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corresponding recombinant inwhich the two ORFs were intact was
also made (TKtrunc). The structures of the recombinants were
confirmed by combined SacI RFLP-Southern blot analysis (Fig. S1)
and full-length genome sequencing (data not shown).
Expression of pORF56 and pORF57 by the recombinants in vitro
was investigated by indirect immunofluorescent staining (Fig. 2).
Staining of cells infected by TKtrunc revealed that pORF56 and
pORF57 were expressed as a nuclear protein and a cytosolic and
nuclear protein, respectively. The specificity of immunostaining
was demonstrated by the absence of staining in cells infected withD56-57. Cells infected with TKtrunc D56-1galk or TKtrunc D56-2galk
expressed a level of pORF57 similar to that of TKtrunc, whereas no
expression of pORF56 was detected, thus demonstrating the
absence of a polar effect of the ORF56 mutations on ORF57
expression. Similarly, immunostaining of cells infected with TKtrunc
D57-1galk or TKtrunc D57-2galk revealed a pattern of pORF56
expression comparable to that of TKtrunc, thus demonstrating the
absence of polar effect of the ORF57 mutations on ORF56 expres-
sion. Staining of pORF57 revealed that both ORF57-mutated viruses
expressed at least part of the remaining sequence of the ORF
(Fig. 2). However, the level of expression of truncated protein was
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barely detectable for TKtruncD57-2galk. Also, the distribution pattern
was affected, with the intact protein expressed as a diffuse cytosolic
protein and the truncated form localized in cytosolic agglutinates.
The results of this experiment demonstrated that the ORF56 and
ORF57 galK singly deleted recombinants were appropriate for
testing the relative contribution of these two genes to the safety
profile of D56-57.
3.2. Effect of deleting ORF56 or ORF57 on CyHV-3 virulence in vivo
Fish were inoculated with the ORF56 or ORF57 galK singly
deleted recombinants, or with TKtrunc and D56-57 as controls for
virulence and attenuation, respectively, by immersion in water
containing virus (Fig. 3). An additional group of fish was mock-
infected.
Fish infected with TKtrunc exhibited all the clinical signsFig. 4. Production of ORF57 nonsense and revertant recombinants. (A) Schematic repre
arrows, and predicted promoters in the ORF57 region are represented by angular black arrow
of ORF57 were mutated to create two in-frame stop codons and one novel restriction site in
coordinates correspond to the reference CyHV-3 sequence available in GenBank (NC_00912
Short names for the recombinants used in the text are shown in bold font. Genotypes for Oassociated with CyHV-3 disease, including apathy, folding of the
dorsal fin, hyperemia, increased mucus secretion, skin lesions,
suffocation, erratic swimming and loss of equilibrium. Fish infected
with TKtrunc D56-1galk or TKtrunc D56-2galk also expressed severe
clinical signs, and survival rates were comparable to, or lower than,
that of fish infected with TKtrunc (p ¼ 0.81 (ns) and p < 0.05 (*),
respectively). In contrast, fish infected with TKtrunc D57-1galk or
TKtrunc D57-2galk expressed mild disease, and survival rates were
comparable to that observed for fish infected with D56-57 (p¼ 0.16
(ns) and p ¼ 0.32 (ns), respectively). However, although clinical
signs were very limited in fish infected with D56-57 (a few exhib-
iting folding of the dorsal fin for a day or two), infectionwith TKtrunc
D57-1galk or TKtrunc D57-2galk led to obvious clinical signs for few
days in all fish, including folding of the dorsal fin and skin hyper-
emia. These results revealed that TKtrunc D57-1galk and TKtrunc
D57-2galk are less attenuated than D56-57. This weaker attenuation
could be due to expression of pORF57 as a truncated protein, or to asentation of the structures of ORF57 nonsense loci. CyHV-3 ORFs are represented by
s. In-frame ATG codons in ORF57 are indicated by dark grey vertical lines. Three regions
each. Mutated nucleotides are underlined, and stop codons are shown by asterisks. All
7.1). (B) Flow chart of the production of ORF57 nonsense and revertant recombinants.
RF55 (TK) and ORF57 are shown to the right. WT, wild-type; Del, deleted.
Fig. 5. Expression of pORF56 and pORF57 by CyHV-3 ORF57 nonsense and revertant recombinants. CCB cells were infected with the viruses indicated on the left at 0.05 PFU/cell.
Cells were subjected at 1 dpi to indirect immunofluorescent staining as indicated at the top, detecting pORF56 (green), pORF57 (green, using a pAb against pORF57), CyHV-3
structural proteins (red) and DNA (DAPI). Scale bars ¼ 20 mm.
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observed for D56-57. Nonetheless, these experiments demon-
strated that ORF57 is a key CyHV-3 virulence factor.3.3. Production of an ORF57 recombinant virus encoding multiple
stop codons
To investigate further the role of ORF57 as a virulence factor and
to test the potential of a recombinant specifically lacking ORF57 as a
vaccine candidate, an ORF57 nonsense mutant containing a wild-
type TK locus was produced (D57ns; Fig. 4). Point mutations were
made at three separate locations in ORF57 in order to create in-
frame stop codons and novel restriction sites (57NS1-3; Fig. 4A).
A wild-type recombinant (WT) and a recombinant in which the
mutated ORF57 was reverted to wild-type were also produced
(57Rev) (Fig. 4B). The structures of the recombinants were
confirmed by RFLP, Southern blot analysis (Fig. S2A), a combined
PCR-restriction digestion approach (Fig. S2B) and full length
genome sequencing (data not shown).
Expression of pORF56 and pORF57 by these recombinants was
investigated by immunofluorescent staining (Fig. 5). Staining of
pORF56 revealed similar expression by D57ns, 57Rev or WT. Stain-
ing of pORF57 was performed with a pAb raised against the entire
protein in order to reveal the production of truncated forms
potentially expressed by D57ns (note that pORF57 staining in Fig. 2
was performed by using a mAb) (Fig. 5). Immunostaining of cells
infected by WT and 57Rev revealed expression of pORF57, whereas
no staining was observed in cells infected with D56-57 or D57ns
(Fig. 5). These experiments demonstrated that D57ns and 57Rev
were appropriate for testing the relative contributions of ORF57 to
the safety and efficacy profile of D56-57 as a candidate vaccine.3.4. Effect of ORF57 deletion on CyHV-3 growth in vitro
The D56-57 has been shown to have a growth defect in vitro(Boutier et al., 2015b). D57ns was used to determine the relative
contributionof the loss ofORF57 function to this defect. BothD56-57
and D57ns expressed significantly smaller plaques than WT and
57Rev (p < 0.001 (***)) (Fig. 6A), and D57ns expressed plaques that
were significantly larger than those ofD56-57 (p< 0.001 (***)). Viral
replication in vitro was also investigated by growth curve assay at
0.05 and 1 PFU/cell (Fig. 6B). Consistent with earlier observations
(Boutier et al., 2015b), and independent of the multiplicity of
infection used,D56-57 produced fewer infectious particles thanWT
and 57Rev (p < 0.001 (***)). Similarly, D57ns produced fewer infec-
tious particles (p< 0.001 (***)) than these two control viruses. These
experiments showed that loss of ORF57 function contributes greatly
to the viral replication defect observed for D56-57.3.5. Testing of an ORF57 deleted recombinant as an attenuated
vaccine candidate against CyHV-3
Fish were inoculated at two different doses with D57ns, 57Rev,
WT or D56-57 by immersion in water containing the virus (Fig. 7),
or were mock-infected. Fish infected with 57Rev expressed severe
clinical signs, and the survival curves were comparable to those for
WT (p ¼ 0.18 and 0.74 (ns) at 40 and 400 PFU/ml, respectively)
(Fig. 7). For both WT and 57Rev, one of the four tanks infected at
40 PFU/ml did not show any clinical signs and mortalities, sug-
gesting an unusually low susceptibility of fish at the time of
infection. Fish infected by D57ns expressed mild symptoms but
survival rates were comparable to those observed with D56-57
(p¼ 0.32 and 0.57 (ns) at 40 and 400 PFU/ml, respectively). Survival
rates following D57ns and D56-57 infection were similar to those of
mock-infected groups (p ¼ 0.32 and 0.16 (ns), respectively, at
400 PFU/ml). These results further demonstrate the role of ORF57
as a key virulence factor.
To assess the level of immune protection conferred by primary
infection with D57ns or D56-57, fish infected with these viruses
were challenged by cohabitationwith carp infected by theWT FL or
Fig. 6. Effect of ORF57 deletion on CyHV-3 replication in vitro. (A) Viral plaque
assay. Data presented are the mean þ SD of 30 measurements. (B) Viral growth assay.
Data presented are the mean þ SD of triplicate measurements. Significant differences
between WT or 57Rev and D56-57 or D57ns are shown in black, and significant dif-
ferences between D56-57 and D57ns are shown in grey.
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the time of the primary infection were used as a negative control
(Fig. 7). All of the mock-infected fish succumbed to challenge with
the M3 strain, and fewer than 20% survived challenge with the FL
strain. Primary infectionwith D56-57 or D57ns induced comparable
levels of protection in a dose-dependent manner. After primary
infection at 400 PFU/ml with either virus, similar levels of relative
percentage survival were observed (about 80% and 90% for the M3
and FL strains, respectively). These results suggest that D56-57 and
D57ns induced similar levels of protection against homologous or
heterologous challenge.4. Discussion
The contributions of ORF56 and ORF57 to the safety and efficacy
profile of the D56-57 attenuated vaccine candidate were addressed
by producing several recombinants and analysing them in vitro and
in vivo. The results demonstrated that ORF57, in contrast to ORF56,
is an essential CyHV-3 virulence factor.
The safety and efficacy profile of a recombinant containing
multiple nonsense mutations in ORF57 (D57ns) was comparable to
that of D56-57 (Fig. 7). The more severe clinical signs observed
following infection with TKtrunc D57-1galk or TKtrunc D57-2galk,
compared to those observed with D57ns, suggest that the truncated
ORF57 proteins expressed by these mutants may retain partial
function (Figs. 2 and 5). In contrast, expression of truncated pro-
teins by D56-57 was not detected, even though this virus retains
the major part of ORF57 (Figs. 2 and 5). The immune protection
conferred by the D57ns was comparable to that of D56-57 (Fig. 7).
Our former study on the development of the D56-57 virus as an
attenuated recombinant vaccine candidate demonstrated that it
confers a mucosal immunity at the portal of entry (Boutier et al.,
2015b). Further studies are required to determine whether the
D57ns confers also this type of protection and to establish correlates
of protection/immunity associated with long-term protection
against CyHV-3 disease. It is already known that anti-CyHV-3 an-
tibodies do not represent correlates of protection (Perelberg et al.,
2008). Indeed, as early as 280 dpi, the titer of anti-CyHV-3 anti-
bodies in previously infected fish is only slightly higher or com-
parable to that of naive fish. Nevertheless, immunized fish, even
those in which antibodies are no longer detectable, are resistant to
a lethal challenge, possibly because of the subsequent rapid
response of B and T memory cells to antigen restimulation
(Perelberg et al., 2008).
ORF57 is conserved among the cypriniviruses, which currently
comprise CyHV-1, CyHV-2, CyHV-3 and AngHV-1, with the likeli-
hood of an expanded list in future (Doszpoly et al., 2015). Amino
acid sequence similarity in ORF57 ranges from 67.5 to 72.4% among
the three cyprinid herpesviruses, and from 57.9% to 60.4% between
these viruses and AngHV-1 (Table S2). A homologue is also present
in a virus in a different family, crocodile poxvirus (CrPV) (Aoki et al.,
2007; Davison et al., 2013; van Beurden et al., 2010; Waltzek et al.,
2009), suggesting that horizontal gene transfer may have occurred.
The present study suggests that ORF57 orthologues in other
pathogenic viruses in the genus Cyprinivirus may offer promising
targets for the design of attenuated recombinant vaccines.
To our knowledge, no studies have been reported on the role of
any ORF57 orthologue, and extensive bioinformatic analyses have
not shed any light on possible functions. CyHV-3 pORF57 is known
to be abundant in virus particles (Michel et al., 2010; van Beurden
et al., 2011), and its orthologue in AngHV-1 (pORF35) has been
described as an abundant constituent of the virion tegument (van
Beurden et al., 2011). This property is consistent with the diffuse,
mainly cytoplasmic expression pattern of pORF57 in CyHV-3-
infected cells (Figs. 2 and 5). D57ns will be a valuable tool in
unravelling the roles of ORF57 in the replication cycle of CyHV-3
in vitro and in vivo.
Aquaculture is the fastest growing food production sector in the
world. Despite the devastating losses caused by alloherpesviruses,
no commercial vaccines are available to control these pathogens.
The present study is the first to identify an essential virulence factor
in one of these viruses. The presence of an orthologue in all other
cypriniviruses opens new possibilities for the development of
prophylactic vaccines against this group of economically important
viruses.
Fig. 7. Effect in vivo of nonsense mutations in ORF57. In the panels on the left, the level of attenuation (safety) of D57ns was tested in carp. WT and 57 Rev were used as positive
controls for virulence, and D56-57 was used as a control for attenuation. Fish (a total of 80 fish distributed in 4 tanks, average weight 2.42 ± 0.95 g, 6 months old) were infected by
immersion for 2 h in water containing 40 (B) or 400 (x) PFU/ml of virus, or were mock infected (◊). Immune protection induced by the primary infection (efficacy) was assessed at
42 dpi. Two of the four tanks initially infected with D56-57 or D57ns, or mock-infected, were challenged by cohabitation with wild-type strain FL-infected fish (middle column), and
the two others were challenged by cohabitation with wild-type strain M3-infected fish (right column). Data are presented as mean survival rate (safety, mean of 4 tanks; efficacy,
mean of 2 tanks) expressed according to the number of fish at the time of primary infection (safety) or challenge (efficacy).
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